Pentasa · DIN 02099683 · 500 mg · Del-Release tablet
General benefitMarketed · checked November 18, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
No interchangeable product listed in the Ontario extract
Pentasa · DIN 02099683
Manufacturer: Ferring Inc.; listing date 1996-10-01
Health Canada: Marketed since 1999-04-01 · brand PENTASA · ATC A07EC02 MESALAZINE · form Tablet (extended-release) · route Oral · ingredients MESALAZINE 500 MG · company Ferring inc · schedule Prescription
Pentasa: Formulary list price $0.78 per unit (the source does not state the unit; exact figure $0.7770). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02099683)
Source record
DIN 02099683: Pentasa
Raw flags: sec3=Y
Item: 564000049; group id 672; item number 1668; lccId None; manufacturer id FEI
Source form: Del-Release Tab; strength: 500mg
Recorded listing: General benefit
Source prices (unrounded): $0.7770; ministry $0.7770
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02099683
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=16855
Shortage status: not checked (no credentials)